Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Combating AMR with Cutting-Edge Antimicrobials That Outsmart Multidrug-Resistant Bacteria with Kelvin Cooper Lakewood-Amedex TRANSCRIPT

Download PDF

Jul 9, 2026

Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics, has developed a novel class of antimicrobials that operate by disrupting bacterial and fungal cell membranes, rapidly killing the microorganisms. Traditional antimicrobials work by inhibiting bacterial growth, but bacteria have evolved resistance mechanisms against...

Combating AMR with Cutting-Edge Antimicrobials That Outsmart Multidrug-Resistant Bacteria with Kelvin Cooper Lakewood-Amedex

Jul 9, 2026

New Hepatitis B Oral Treatment Blocks Viral Integration and Progression with Lawrence Blatt Aligos Therapeutics TRANSCRIPT

Download PDF

Jan 7, 2026

Lawrence Blatt, Chairman, President, and CEO of Aligos Therapeutics, describes the current gaps in treating the hepatitis B virus and how the disease can potentially lead to end-stage liver disease and liver cancer. Current therapies were initially developed for HIV and can suppress the virus but not eliminate or...

New Hepatitis B Oral Treatment Blocks Viral Integration and Progression with Lawrence Blatt Aligos Therapeutics

Jan 7, 2026

Pioneering Anti-Inflammatory Therapeutics with Dr. Niels Riedemann InflaRx TRANSCRIPT

Download PDF

Jan 10, 2025

Niels Riedemann, the CEO, Founder, and Executive Director of the Board of InflaRx, explains that InflaRx develops pioneering anti-inflammatory therapeutics against a specific portion of the complement cascade, a part of the body’s immune system that responds to infectious microbes. By applying its proprietary...